Kevin Jerrold Peterson

Kevin Jerrold Peterson

Auto-generated profile, based on publicly available information

Kevin Jerrold Peterson

Department of Health Sciences Research Mayo Clinic 200 First Street SW 55905 Rochester MN

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
SFSunyang Fu
Sunyang Fu
DCDavid Chen
David Chen
HHHuan He
Huan He
SLSijia Liu
Sijia Liu
SMSungrim Moon
Sungrim Moon
HLHongfang Liu
Hongfang Liu

14 July 2023 in Interactive Journal of Medical Research
Verified
Journal Article
Open access
TBTracey A Brereton
Tracey A Brereton
MMMomin M. Malik
Momin M. Malik
MLMark Lifson
Mark Lifson
JGJason D Greenwood
Jason D Greenwood
KPKevin J Peterson
Kevin J Peterson
SOShauna M Overgaard
Shauna M Overgaard
Background: Despite the touted potential of artificial intelligence (AI) and machine learning (ML) to revolutionize health care, clinical decision support tools, herein referred to as medical modeling software (MMS), have yet to realize the anticipated benefits. One proposed obstacle is the acknowledged gaps in AI translation. These gaps stem partly from the fragmentation of processes and resources to support MMS transparent documentation. Consequently, the absence of transparent reporting hinders the provision of evidence to support the implementation of MMS in clinical practice, thereby serving as a substantial barrier to the successful translation of software from research settings to clinical practice. Objective: This study aimed to scope the current landscape of AI- and ML-based MMS documentation practices and elucidate the function of documentation in facilitating the translation of ethical and explainable MMS into clinical workflows. Methods: A scoping review was conducted in accordance with PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews) guidelines. PubMed was searched using Medical Subject Headings key concepts of AI, ML, ethical considerations, and explainability to identify publications detailing AI- and ML-based MMS documentation, in addition to snowball sampling of selected reference lists. To include the possibility of implicit documentation practices not explicitly labeled as such, we did not use documentation as a key concept but as an inclusion criterion. A 2-stage screening process (title and abstract screening and full-text review) was conducted by 1 author. A data extraction template was used to record publication-related information; barriers to developing ethical and explainable MMS; available standards, regulations, frameworks, or governance strategies related to documentation; and recommendations for documentation for papers that met the inclusion criteria. Results: Of the 115 papers retrieved, 21 (18.3%) papers met the requirements for inclusion. Ethics and explainability were investigated in the context of AI- and ML-based MMS documentation and translation. Data detailing the current state and challenges and recommendations for future studies were synthesized. Notable themes defining the current state and challenges that required thorough review included bias, accountability, governance, and explainability. Recommendations identified in the literature to address present barriers call for a proactive evaluation of MMS, multidisciplinary collaboration, adherence to investigation and validation protocols, transparency and traceability requirements, and guiding standards and frameworks that enhance documentation efforts and support the translation of AI- and ML-based MMS. Conclusions: Resolving barriers to translation is critical for MMS to deliver on expectations, including those barriers identified in this scoping review related to bias, accountability, governance, and explainability. Our findings suggest that transparent strategic documentation, aligning translational science and regulatory science, will support the translation of MMS by coordinating communication and reporting and reducing translational barriers, thereby furthering the adoption of MMS.

16 August 2020 in Journal of Biomedical Informatics
Verified
Journal Article
Closed access
KPKevin J. Peterson
Kevin J. Peterson
GJGuoqian Jiang
Guoqian Jiang
HLHongfang Liu
Hongfang Liu

15 January 2024 in JMIR Formative Research
Verified
Journal Article
Open access
LZLu Zheng
Lu Zheng
JOJoshua W Ohde
Joshua W Ohde
SOShauna M Overgaard
Shauna M Overgaard
TBTracey A Brereton
Tracey A Brereton
KJKristelle Jose
Kristelle Jose
YJYoung Juhn
Young Juhn
Background: Personalized asthma management depends on a clinician’s ability to efficiently review patient’s data and make timely clinical decisions. Unfortunately, efficient and effective review of these data is impeded by the varied format, location, and workflow of data acquisition, storage, and processing in the electronic health record. While machine learning (ML) and clinical decision support tools are well-positioned as potential solutions, the translation of such frameworks requires that barriers to implementation be addressed in the formative research stages. Objective: We aimed to use a structured user-centered design approach (double-diamond design framework) to (1) qualitatively explore clinicians’ experience with the current asthma management system, (2) identify user requirements to improve algorithm explainability and Asthma Guidance and Prediction System prototype, and (3) identify potential barriers to ML-based clinical decision support system use. Methods: At the “discovery” phase, we first shadowed to understand the practice context. Then, semistructured interviews were conducted digitally with 14 clinicians who encountered pediatric asthma patients at 2 outpatient facilities. Participants were asked about their current difficulties in gathering information for patients with pediatric asthma, their expectations of ideal workflows and tools, and suggestions on user-centered interfaces and features. At the “define” phase, a synthesis analysis was conducted to converge key results from interviewees’ insights into themes, eventually forming critical “how might we” research questions to guide model development and implementation. Results: We identified user requirements and potential barriers associated with three overarching themes: (1) usability and workflow aspects of the ML system, (2) user expectations and algorithm explainability, and (3) barriers to implementation in context. Even though the responsibilities and workflows vary among different roles, the core asthma-related information and functions they requested were highly cohesive, which allows for a shared information view of the tool. Clinicians hope to perceive the usability of the model with the ability to note patients’ high risks and take proactive actions to manage asthma efficiently and effectively. For optimal ML algorithm explainability, requirements included documentation to support the validity of algorithm development and output logic, and a request for increased transparency to build trust and validate how the algorithm arrived at the decision. Acceptability, adoption, and sustainability of the asthma management tool are implementation outcomes that are reliant on the proper design and training as suggested by participants. Conclusions: As part of our comprehensive informatics-based process centered on clinical usability, we approach the problem using a theoretical framework grounded in user experience research leveraging semistructured interviews. Our focus on meeting the needs of the practice with ML technology is emphasized by a user-centered approach to clinician engagement through upstream technology design.

15 November 2012
Verified
Conference Paper
Open access
PDF file
MSMichael Seedorff
Michael Seedorff
KPKevin J. Peterson
Kevin J. Peterson
LNLaurie A. Nelsen
Laurie A. Nelsen
CCCristian Cocos
Cristian Cocos
JMJennifer B. McCormick
Jennifer B. McCormick
JPJyotishman Pathak
Jyotishman Pathak
It is well-known that the general health information seeking lay-person, regardless of his/her education, cultural background, and economic status, is not as familiar with—or comfortable using—the technical terms commonly used by healthcare professionals. One of the primary reasons for this is due to the differences in perspectives and understanding of the vocabulary used by patients and providers even when referring to the same health concept. To bridge this “knowledge gap,” consumer health vocabularies are presented as a solution. In this study, we introduce the Mayo Consumer Health Vocabulary (MCV)—a taxonomy of approximately 5,000 consumer health terms and concepts—and develop text-mining techniques to expand its coverage by integrating disease concepts (from UMLS) as well as non-genetic (from deCODEme) and genetic (from GeneWiki+ and PharmGKB) risk factors to diseases. These steps led to adding at least one synonym for 97% of MCV concepts with an average of 43 consumer friendly terms per concept. We were also able to associate risk factors to 38 common diseases, as well as establish 5,361 Disease:Gene pairings. The expanded MCV provides a robust resource for facilitating online health information searching and retrieval as well as building consumer-oriented healthcare applications.

27 June 2023 in JMIR Medical Informatics
Verified
Journal Article
Open access
LWLiwei Wang
Liwei Wang
HHHuan He
Huan He
AWAndrew Wen
Andrew Wen
SMSungrim Moon
Sungrim Moon
SFSunyang Fu
Sunyang Fu
HLHongfang Liu
Hongfang Liu
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: A patient’s family history (FH) information significantly influences downstream clinical care. Despite this importance, there is no standardized way to capture FH information in electronic health records (EHR) and a substantial portion of FH information is frequently embedded in clinical notes. This renders FH information difficult to use in downstream data analytics or clinical decision support applications. To address this issue, a natural language processing (NLP) system capable of extracting and normalizing FH information can be used. Objective: In this study, we aimed to construct an FH lexical resource for information extraction and normalization. Methods: we exploited a transformer-based method to construct an FH lexical resource leveraging a corpus consisting of clinical notes generated as part of primary care. The usability of the lexicon was demonstrated through the development of an expert-based baseline FH system. We also experimented with a deep-learning-based module for FH information extraction. Previous FH challenge datasets were used for evaluation. Results: The resulting lexicon contains 33,603 lexicon entries normalized to 6,408 concept unique identifiers (CUIs) of the Unified Medical Language System (UMLS) and 15,126 codes of the Systematized Nomenclature of Medicine Clinical Terms (SNOMED-CT), with an average number of 5.4 variants per concept. The performance evaluation demonstrates that the combination of the baseline FH system with a state-of-the-art deep learning-based FH module can improve the recall of FH information using the BioCreative/N2C2 family history challenge dataset. Conclusions: The resulting lexicon and baseline FH system are freely available through the Open Health Natural Language Processing (OHNLP) GitHub. Clinical Trial: NA